1. Home
  2. OCUL vs DV Comparison

OCUL vs DV Comparison

Compare OCUL & DV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCUL
  • DV
  • Stock Information
  • Founded
  • OCUL 2006
  • DV 2008
  • Country
  • OCUL United States
  • DV United States
  • Employees
  • OCUL N/A
  • DV N/A
  • Industry
  • OCUL Biotechnology: Pharmaceutical Preparations
  • DV Computer Software: Prepackaged Software
  • Sector
  • OCUL Health Care
  • DV Technology
  • Exchange
  • OCUL Nasdaq
  • DV Nasdaq
  • Market Cap
  • OCUL 2.3B
  • DV 1.9B
  • IPO Year
  • OCUL 2014
  • DV 2021
  • Fundamental
  • Price
  • OCUL $12.24
  • DV $10.29
  • Analyst Decision
  • OCUL Strong Buy
  • DV Buy
  • Analyst Count
  • OCUL 10
  • DV 17
  • Target Price
  • OCUL $22.33
  • DV $16.56
  • AVG Volume (30 Days)
  • OCUL 2.1M
  • DV 3.8M
  • Earning Date
  • OCUL 11-04-2025
  • DV 11-07-2025
  • Dividend Yield
  • OCUL N/A
  • DV N/A
  • EPS Growth
  • OCUL N/A
  • DV N/A
  • EPS
  • OCUL N/A
  • DV 0.26
  • Revenue
  • OCUL $55,783,000.00
  • DV $733,324,000.00
  • Revenue This Year
  • OCUL N/A
  • DV $18.45
  • Revenue Next Year
  • OCUL $17.75
  • DV $11.70
  • P/E Ratio
  • OCUL N/A
  • DV $39.16
  • Revenue Growth
  • OCUL N/A
  • DV 14.86
  • 52 Week Low
  • OCUL $5.79
  • DV $7.64
  • 52 Week High
  • OCUL $13.85
  • DV $23.11
  • Technical
  • Relative Strength Index (RSI)
  • OCUL 59.26
  • DV 38.94
  • Support Level
  • OCUL $11.08
  • DV $10.19
  • Resistance Level
  • OCUL $12.03
  • DV $10.50
  • Average True Range (ATR)
  • OCUL 0.53
  • DV 0.49
  • MACD
  • OCUL 0.13
  • DV -0.01
  • Stochastic Oscillator
  • OCUL 89.86
  • DV 69.44

About OCUL Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

About DV DoubleVerify Holdings Inc.

DoubleVerify Holdings Inc is a digital media measurement and analytics software platform. Its solutions provide advertisers with unbiased data analytics that enable them to increase the effectiveness, quality, and return on their digital advertising investments. Its DV Authentic Ad, a proprietary metric of digital media quality, measures whether a digital ad was delivered in a brand-suitable environment, fully viewable, by a real person, and in the intended geography. The company's software interface, DV Pinnacle, delivers these metrics to customers in real time, allowing them to access critical performance data on their digital transactions. Geographically, the company operates in the United States and also has a presence in Germany, Singapore, France, Canada, Japan, and other countries.

Share on Social Networks: